Dr Alison Cave, the organisation's chief safety officer, said: "Buying semaglutide from illegally trading online suppliers significantly increases the risk of getting a product which is either falsified or not licensed for use in the UK." She said injecting such products "may put your health at risk"
The primary mechanism of action involves binding to GLP-1 receptors on pancreatic beta cells, which stimulates glucose-dependent insulin secretion and suppresses inappropriate glucagon release
It works across four key areas: fuel transport and mobilisation mitochondrial energy production muscle function and performance metabolic efficiency and resilience Functional categories - energy support in action Fuel Transport & Mobilisation - Supporting the movement of fatty acids into the cell, making fuel available for energy production
A preclinical safety evaluation of BPC-157 published in Regulatory Toxicology and Pharmacology found this peptide to have a favorable safety profile
The combination of these three compounds creates a comprehensive peptide research platform for scientific investigation
FOXO4-DRI is intended strictly for research use only